Highlights and goals of IMPAKT 2012
17 May 2012
Highlights and goals of IMPAKT 2012
PI3K and the heterogeneity of small tumour breast cancer
Molecularly characterising triple negative breast cancer
Endocrine therapy and endocrine resistant breast cancer
Neoadjuvant therapy and PCR through chemotherapy prior to surgery
Minimising recurrence by using most effective treatment
Targeting the PI3K/mTOR pathway
Use of metformin against breast cancer
Advances in radiation oncology
Effects of lifestyle change in cancer patients
Involving patients in care decisions
Long term survival with testicular cancer